Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: does a gold standard dsDNA assay exist?
Antonio Trujillo-AguileraRaquel Bernardo SerranoAna NavasJuan Alcaide MolinaPaula Alvarez RomeroAurora Jurado RogerPublished in: Lupus science & medicine (2023)
The study showed that CLIFT could be negative in both treated and newly diagnosed SLE, thus underlining the importance of follow-up of dsDNA-positive results using solid-phase tests. Therefore, quantitative tests such as FEIA could add value to the diagnosis and management of patients with suspected SLE.